Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Comparative genomics of BCG vaccines by whole-genome DNA microarray.

Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM.

Science. 1999 May 28;284(5419):1520-3.

2.

Genomics of Mycobacterium bovis.

Gordon SV, Eiglmeier K, Garnier T, Brosch R, Parkhill J, Barrell B, Cole ST, Hewinson RG.

Tuberculosis (Edinb). 2001;81(1-2):157-63. Review.

PMID:
11463237
3.

Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence.

Ganguly N, Siddiqui I, Sharma P.

Tuberculosis (Edinb). 2008 Nov;88(6):510-7. doi: 10.1016/j.tube.2008.05.002. Epub 2008 Jul 21. Review.

PMID:
18640874
4.

[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].

Prygiel M, Janaszek-Seydlitz W, Bucholc B.

Przegl Epidemiol. 2011;65(4):621-8. Review. Polish.

PMID:
22390050
5.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Epub 2009 Feb 20. Review.

PMID:
19164935
6.

Correlation between BCG genomics and protective efficacy.

Behr MA.

Scand J Infect Dis. 2001;33(4):249-52. Review.

PMID:
11345214
7.

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.

Dietrich G, Viret JF, Hess J.

Vaccine. 2003 Jan 30;21(7-8):667-70. Review.

PMID:
12531337
8.

Development of vaccines to control bovine tuberculosis in cattle and relationship to vaccine development for other intracellular pathogens.

Buddle BM, Pollock JM, Skinner MA, Wedlock DN.

Int J Parasitol. 2003 May;33(5-6):555-66. Review.

PMID:
12782055
9.

Comparative genomics of BCG vaccines.

Behr MA.

Tuberculosis (Edinb). 2001;81(1-2):165-8. Review.

PMID:
11463238
10.

BCG Vaccines.

Tran V, Liu J, Behr MA.

Microbiol Spectr. 2014 Feb;2(1):MGM2-0028-2013. doi: 10.1128/microbiolspec.MGM2-0028-2013. Review.

PMID:
26082111
11.

Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.

Dietrich G, Viret JF, Hess J.

Int J Med Microbiol. 2003 Feb;292(7-8):441-51. Review.

PMID:
12635927
12.

Recombinant Mycobacterium bovis BCG.

Bastos RG, Borsuk S, Seixas FK, Dellagostin OA.

Vaccine. 2009 Nov 5;27(47):6495-503. doi: 10.1016/j.vaccine.2009.08.044. Epub 2009 Aug 29. Review.

PMID:
19720367
13.

Development of new vaccines and diagnostic reagents against tuberculosis.

Mustafa AS.

Mol Immunol. 2002 Sep;39(1-2):113-9. Review.

PMID:
12213334
14.

The use of mutant mycobacteria as new vaccines to prevent tuberculosis.

Hernàndez Pando R, Aguilar LD, Infante E, Cataldi A, Bigi F, Martin C, Gicquel B.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):203-10. Epub 2006 Mar 20. Review.

PMID:
16542875
15.

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P.

Tuber Lung Dis. 1999;79(4):243-50. Review.

PMID:
10692993
17.

Vaccination of cattle against Mycobacterium bovis.

Buddle BM.

Tuberculosis (Edinb). 2001;81(1-2):125-32. Review.

PMID:
11463233
18.

[From genetics to genomics in the rational design of new Mycobacterium tuberculosis vaccines].

Bocanegra-García V, Valencia-Delgadillo J, Cruz-Pulido W, Cantú-Ramírez R, Rivera-Sánchez G, Palma-Nicolás JP.

Enferm Infecc Microbiol Clin. 2011 Oct;29(8):609-14. doi: 10.1016/j.eimc.2011.04.004. Review. Spanish.

PMID:
21684635
19.

Manipulation of BCG vaccine: a double-edged sword.

Singh VK, Srivastava R, Srivastava BS.

Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):535-43. doi: 10.1007/s10096-016-2579-y. Epub 2016 Jan 25. Review.

PMID:
26810060
20.

Microevolution of BCG substrains.

Krysztopa-Grzybowska K, Lutyńska A.

Postepy Hig Med Dosw (Online). 2016 Dec 21;70(0):1259-1266. Review.

Supplemental Content

Support Center